Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors

G. Schiller, S. A. Feig, M. Territo, M. Wolin, M. Lill, T. Belin, L. Hunt, S. Nimer, R. Champlin, J. Gajewski

    Research output: Contribution to journalArticle

    49 Scopus citations

    Abstract

    Bone marrow transplantation from a histocompatible sibling donor may produce complete remission in patients with induction failure or relapsed acute leukaemia. Through the National Marrow Donor Program, histocompatible bone marrow from unrelated donors has become available for high-risk patients. In this study we analyse the results of matched unrelated bone marrow transplant in 55 patients with highly advanced acute myelogenous and acute lymphoblastic leukaemia. 28 patients with advanced acute lymphoblastic leukaemia and 27 patients with advanced acute myelogenous leukaemia, age 2-51, were treated with high-dose chemoradiotherapy and transplantation of 6/6 HLA matched (n = 46) or one antigen mismatched (n = 9) unrelated donor bone marrow. After a median follow-up of 36 months, 13 patients remain alive 17-74 months after transplant for a 2-year actuarial disease-free and overall survival of 23 ± 12% (median disease-free survival 3.5 months). The actuarial risk of relapse is 24 ± 16% at 1 year. Moderate to severe graft-versus-host disease occurred in 27/47 evaluable patients (57%). Significant prognostic factors for poor leukaemia-free survival include age >21, abnormal karyotype, and active leukaemia at the time of transplant. Other pretreatment characteristics such as gender or type of leukaemia were not significant prognostic factors. Our results show that matched unrelated bone marrow transplant for patients with advanced acute leukaemia may provide long-term leukaemia-free survival, but transplant-related complications produce a significant impact on survival with older age and adverse disease characteristics predicting for poor prognosis.

    Original languageEnglish (US)
    Pages (from-to)72-78
    Number of pages7
    JournalBritish Journal of Haematology
    Volume88
    Issue number1
    DOIs
    StatePublished - Jan 1 1994

    Keywords

    • Acute leukaemia
    • Allogeneic BMT
    • Relapsing
    • Resistant
    • Unrelated donor

    ASJC Scopus subject areas

    • Hematology

    Fingerprint Dive into the research topics of 'Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors'. Together they form a unique fingerprint.

  • Cite this

    Schiller, G., Feig, S. A., Territo, M., Wolin, M., Lill, M., Belin, T., Hunt, L., Nimer, S., Champlin, R., & Gajewski, J. (1994). Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors. British Journal of Haematology, 88(1), 72-78. https://doi.org/10.1111/j.1365-2141.1994.tb04979.x